Belgium Antiinfective Medicine Sales is set to reach $862.61 Million by 2026 from $830.39 Million, will be up 3.4% per year. Germany, South Korea and Italy respectively ranked numbers 2, 3 and 4 in this ranking.
How does Belgium perform in Anti-Infective?
Penicillins and Streptomycins in Dosage Market Size Value in Belgium
- US Dollars
- 2010 to 2023
- ReportLinker Research
Penicillins and Streptomycins in Dosage Market Size Value Per Capita in Belgium
- US Dollars Per Capita
- 2010 to 2023
- ReportLinker Research
Forecast: Penicillins and Streptomycins in Dosage Market Size Value in Belgium
- US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Penicillins and Streptomycins in Dosage Market Size Value Per Capita in Belgium
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Belgium
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antibacterial Medicine Sales in Belgium
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Antibacterial Medicine Sales in Belgium
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Antibacterial Medicine Sales in Belgium
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Belgium
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antibacterial Medicine Sales in Belgium
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research